[{"NetIncomeLoss_1_Q1_USD":26779000.0,"LiabilitiesNoncurrent_0_Q1_USD":91232000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":6052000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":1399000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-7086000.0,"Depreciation_1_Q1_USD":1508000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":3301000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1002000.0,"AssetsCurrent_0_Q1_USD":177616000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":31369000.0,"SellingAndMarketingExpense_1_Q1_USD":7021000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":258000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1346000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"Land_0_Q1_USD":997000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":20874000.0,"Assets_0_Q1_USD":423930000.0,"ShareBasedCompensation_1_Q1_USD":1241000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":6213000.0,"LegalFees_1_Q1_USD":1227000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":7714000.0,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":384000.0,"OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParent_1_Q1_USD":21000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":462000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":707000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1_Q1_USD":77000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-2682000.0,"CommonStockSharesIssued_0_Q1_shares":43124190.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":7980000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":11938000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":-6000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":6810000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":46190000.0,"EarningsPerShareBasic_1_Q1_USD":0.62,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":7993000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":1644000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":43779000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-691000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":7469000.0,"CommonStockValue_0_Q1_USD":null,"Revenues_1_Q1_USD":92917000.0,"GoodwillPeriodIncreaseDecrease_1_Q1_USD":682000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":10000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-5826000.0,"OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_1_Q1_USD":-14000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.22,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-10000000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":1047000.0,"OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_1_Q1_USD":-42000.0,"CommonStockNoParValue_0_Q1_USD":0.0,"IncreaseDecreaseInInventories_1_Q1_USD":5941000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":30038000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":2221000.0,"OtherAssetsNoncurrent_0_Q1_USD":210326000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":63193000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":4513000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":141395000.0,"OperatingLeaseLiability_0_Q1_USD":6348000.0,"CommonStockSharesAuthorized_0_Q1_shares":71000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":92917000.0,"BuildingsAndImprovementsGross_0_Q1_USD":32320000.0,"OperatingIncomeLoss_1_Q1_USD":34664000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":34248000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1241000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":25121000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":13868000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":43098000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":11303000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1873000.0,"LiabilitiesCurrent_0_Q1_USD":53831000.0,"AccountsPayableCurrent_0_Q1_USD":15348000.0,"NonoperatingIncomeExpense_1_Q1_USD":-416000.0,"InterestExpense_1_Q1_USD":534000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":6244000.0,"LongTermDebtNoncurrent_0_Q1_USD":58824000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":7985000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":80976000.0,"GrossProfit_1_Q1_USD":61548000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.036,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":681000.0,"PreferredStockNoParValue_0_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":63193000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q1_USD":555000.0,"OperatingLeasePayments_1_Q1_USD":494000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":3007000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"ReceivablesNetCurrent_0_Q1_USD":40936000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":10653000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":35988000.0,"Goodwill_0_Q1_USD":114868000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":5651000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":3259000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":7976000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":4032000.0,"InventoryNet_0_Q1_USD":67243000.0,"InvestmentIncomeInterest_1_Q1_USD":9000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":127166000.0,"PreferredStockValue_0_Q1_USD":null,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-852000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":423930000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":10581000.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"DerivativeLiabilitiesNoncurrent_0_Q1_USD":693000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":111082000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1835000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":6289000.0,"OperatingExpenses_1_Q1_USD":26884000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":80000.0,"ProfitLoss_1_Q1_USD":26779000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":169000.0,"StockholdersEquity_0_Q1_USD":278867000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":2086000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_1_Q1_USD":3301000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":579000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":7296000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":136073000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":9679000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1776000.0,"EarningsPerShareDiluted_1_Q1_USD":0.61,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":7967000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":75094000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1590000.0,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210205"}]